Global Cord Blood Corporation Files Annual Report on Form 20-F

(Moderate)

(Neutral)

Rhea-AI Summary

On August 16, 2022, Global Cord Blood Corporation (NYSE: CO) announced the filing of its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission. This report includes audited financial statements for the fiscal year ending March 31, 2022. Investors can access the Form 20-F via the SEC's website or through the Investor Relations section of GCBC's website. The company specializes in umbilical cord blood banking and related services in China.

Positive

Filed its Annual Report on Form 20-F, providing transparency.
Includes audited financial statements, enhancing credibility.

Negative

No specific financial performance metrics disclosed in the PR, limiting investors' ability to assess company health.

News Market Reaction – CO

-1.63%

-1.63% Session move

In the trading session that priced this news, CO declined 1.63%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

08/16/2022 - 04:16 PM

HONG KONG, Aug. 16, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission. The filed Form 20-F includes audited financial statements for the fiscal year ended March 31, 2022. The Form 20-F can be accessed by visiting the U.S. Securities and Exchange Commission's website at http://www.sec.gov and also be found at the Investor Relations section of GCBC's website at http://ir.globalcordbloodcorp.com.

About Global Cord Blood Corporation

Global Cord Blood Corporation is an umbilical cord blood banking operator serving multiple regions in China. Global Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. For more information, please visit the Company's website at:

http://www.globalcordbloodcorp.com.

View original content:https://www.prnewswire.com/news-releases/global-cord-blood-corporation-files-annual-report-on-form-20-f-301606629.html

SOURCE Global Cord Blood Corporation

FAQ

What is the significance of the Form 20-F filing by Global Cord Blood Corporation?

The Form 20-F filing provides audited financial statements and essential information about the company's fiscal health.

When did Global Cord Blood Corporation file its Annual Report on Form 20-F?

The company filed its Annual Report on Form 20-F on August 16, 2022.

Where can I access the Form 20-F for Global Cord Blood Corporation?

The Form 20-F can be accessed through the SEC's website and the Investor Relations section of GCBC's website.

What fiscal year does the Annual Report on Form 20-F cover for Global Cord Blood Corporation?

The report covers the fiscal year ending March 31, 2022.